Patents Assigned to Queen Elizabeth Hospital
-
Patent number: 11369769Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device 1 such that they may be operated by hand.Type: GrantFiled: November 27, 2019Date of Patent: June 28, 2022Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
-
Patent number: 11129935Abstract: A regional anaesthesia injection apparatus comprising an injection volume determiner. The apparatus configured to determine a volume of a regional anaesthetic injection into a target tissue; an injection pressure determiner configured to determine a pressure of the injection; and a controller coupled to the injection volume determiner and to the injection pressure determiner and configured to provide an injection signal to control injection of fluid into the target tissue based on the determined pressure and the determined volume.Type: GrantFiled: September 23, 2019Date of Patent: September 28, 2021Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
-
Patent number: 10525229Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device 1 such that they may be operated by hand.Type: GrantFiled: September 17, 2018Date of Patent: January 7, 2020Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
-
Patent number: 10463829Abstract: A regional anesthesia injection apparatus comprising an injection volume determiner. The apparatus configured to determine a volume of a regional anesthetic injection into a target tissue; an injection pressure determiner configured to determine a pressure of the injection; and a controller coupled to the injection volume determiner and to the injection pressure determiner and configured to provide an injection signal to control injection of fluid into the target tissue based on the determined pressure and the determined volume.Type: GrantFiled: May 29, 2015Date of Patent: November 5, 2019Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
-
Patent number: 10076630Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device such that they may be operated by hand.Type: GrantFiled: April 24, 2013Date of Patent: September 18, 2018Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
-
Patent number: 8986262Abstract: A sampling connector for use in sampling a body fluid such as arterial blood or cerebrospinal fluid. The sampling connector comprises at least two apertures in fluid communication via a fluid flow conduit and a one-way valve (14) disposed to allow fluid flow from the first aperture, through the fluid flow conduit and out of the second aperture, but not to allow fluid to flow into the second aperture and through the fluid flow conduit to the first aperture. In use, the sampling connector is connected to a body cavity to enable the sampling of a body fluid by withdrawal of the body fluid through the first aperture, and to prevent the introduction of a separate fluid to the body cavity. The first aperture can be within a male end and the second aperture can be within a female end or vice versa. A sampling device comprising a sampling connector according to the present invention and use of the sampling connector and/or sampling device is also claimed.Type: GrantFiled: March 25, 2009Date of Patent: March 24, 2015Assignee: The Queen Elizabeth Hospital King's Lynn NHS TrustInventors: Peter Jeffrey Young, Joseph Joachim Carter
-
Patent number: 8014952Abstract: Certain biomarkers and biomarker combinations are useful in a qualifying lung cancer status in a subject. A diagnostic methodology employing these biomarkers and combinations can detect whether a subject has lung cancer.Type: GrantFiled: December 16, 2003Date of Patent: September 6, 2011Assignees: Queen Elizabeth Hospital, Vermillion, Inc.Inventors: Timothy Tak Chun Yip, Chi Shing Cho, Siu Kie Au, Tai-Tung Yip, Christine Yip, Victor Yip
-
Patent number: 7722866Abstract: The present invention provides methods for inhibiting cancerous growth of a cell using an antibody or an antigen-binding portion thereof which binds to an epitope of EphB4 polypeptide. Purified antibodies of EphB4 are also provided. The invention also provides methods for preventing or treating cancer. The invention also relates to methods of identifying agents that can inhibit cancerous growth of a cell.Type: GrantFiled: September 16, 2003Date of Patent: May 25, 2010Assignee: The Queen Elizabeth Hospital Research Foundation, Inc.Inventor: Sally-Anne Stephenson
-
Patent number: 7455970Abstract: The present invention relates to a method of identifying a subject predisposed to ischemic stroke. The method includes the step of identifying a mutation in the subject that reduces the release rate of tissue plasminogen activator.Type: GrantFiled: July 2, 2004Date of Patent: November 25, 2008Assignees: The Queen Elizabeth Hospital Research Foundation Inc., Adelaide Research & Innovation Pty LtdInventors: Jim Jannes, Monica Anne Hamilton-Bruce, Simon Koblar
-
Publication number: 20080241824Abstract: The present invention relates to a method of identifying a subject predisposed to lacunar stroke. The method includes the step of identifying in the subject the presence of a thymine to cytosine mutation at position -107 in both alleles of the paraoxonase 1 locus.Type: ApplicationFiled: February 18, 2005Publication date: October 2, 2008Applicants: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC., Adelaide Research & Innovation Pty Ltd.Inventors: Jim Jannes, Monica Anne Hamilton-Bruce, Simon Koblar
-
Publication number: 20070105110Abstract: The present invention relates to a method of identifying a subject predisposed to ischemic stroke. The method includes the step of identifying a mutation in the subject that reduces the release rate of tissue plasminogen activator.Type: ApplicationFiled: July 2, 2004Publication date: May 10, 2007Applicants: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC., Adelaide Research & Innovation Pty Ltd.Inventors: Jim Jannes, Monica Hamilton-Bruce, Simon Koblar
-
Publication number: 20060134118Abstract: The present invention provides methods for inhibiting cancerous growth of a cell using an antibody or an antigen-binding portion thereof which binds to an epitope of EphB4 polypeptide. Purified antibodies of EphB4 are also provided. The invention also provides methods for preventing or treating cancer. The invention also relates to methods of identifying agents that can inhibit cancerous growth of a cell.Type: ApplicationFiled: September 16, 2003Publication date: June 22, 2006Applicant: The Queen Elizabeth Hospital Research Foundation Inc.Inventor: Sally-Anne Stephenson
-
Publication number: 20050143463Abstract: The present invention relates to a method of inhibiting endothelial cell proliferation in a biological system, the method including the step of administering to the biological system an effective amount of an alkyl-substituted fatty acid, wherein the alkyl-substituted fatty acid is capable of inhibiting endothelial cell proliferation.Type: ApplicationFiled: November 3, 2004Publication date: June 30, 2005Applicant: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC.Inventor: Ravi Krishnan